by Collectif | 7 Jun, 2016 | Bioethics press synthesis | Embryo research and alternatives
The one and only clinical trial using iPS cells, which was suspended in early summer 2015, is about to resume. Initially launched in Japan in 2014, the aim of this trial is to treat ARMD (Age-Related Macular Degeneration), the first cause of blindness in people over...
by Collectif | 7 Jun, 2016 | Bioethics press synthesis | Embryo research and alternatives
The Belgian Parliament Health Commission has unanimously approved a draft bill “that extends the definition of palliative care”. The aim of those who drafted the law “is to no longer limit care to a patient’s last few weeks of life but to extend it to the advanced or...
by Collectif | 6 Jun, 2016 | Bioethics press synthesis | Preimplantation genetic diagnosis
On Sunday, the people of Switzerland accepted changes to the law governing Medically Assisted Procreation (see Pre-implantation Screening authorised in Switzerland). This legislation currently authorises the creation of twelve embryos for in-vitro fertilisation,...
by Collectif | 6 Jun, 2016 | Bioethics press synthesis | End of life
The 6th of June deadline imposed by the Canadian Supreme Court to alter the Criminal Code has arrived. The C-14 draft law adopted by the Lower House last Tuesday is currently being discussed in the Senate. However, without waiting for the framework of this new...
by Collectif | 6 Jun, 2016 | Bioethics press synthesis | Genome
Six years after the work on bacterial genome synthesis by scientist, Craig Venter,the Science journal unveiled the contents of the “human genome project-write” on 2 June 2016. The key aims are to produce: “A complete human genome” by deciding on...
by Collectif | 5 Jun, 2016 | Bioethics press synthesis | End of life
The reasons for requesting euthanasia in Belgium and the Netherlands “shock us”: “fear of solitude”, refusal to enter a retirement home, anorexia, etc. (seeThe euthanasia of a young Dutch woman: the “extraordinary” failure of a profoundly negative message sent to...